Literature DB >> 21651356

Microsatellite instability in the management of colorectal cancer.

Maria S Pino1, Daniel C Chung.   

Abstract

Microsatellite instability (MSI) is a form of genetic instability caused by alterations in the DNA mismatch repair system. Approximately 15% of colorectal cancers display MSI due to a germline mutation in one of the mismatch repair genes (MLH1, MSH2, MSH6 and PMS2) or to epigenetic silencing of MLH1. Colorectal cancers with MSI have distinctive features, including a tendency to arise in the proximal colon, poor differentiation, lymphocytic infiltration and mucinous or signet-ring histology. Patients with MSI tumors appear to have a better prognosis than those with microsatellite stable tumors, but curiously the responses to 5-fluorouracil-based chemotherapy regimens are poorer with MSI tumors. Preliminary data suggest possible advantages of irinotecan-based regimens, but these findings need validation in well-designed clinical trials.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21651356     DOI: 10.1586/egh.11.25

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  31 in total

1.  Lower prevalence of Lynch syndrome in colorectal cancer patients in a Japanese hospital-based population.

Authors:  Kensuke Kumamoto; Hideyuki Ishida; Okihide Suzuki; Yusuke Tajima; Noriyasu Chika; Koki Kuwabara; Keiichiro Ishibashi; Katsuharu Saito; Koji Nagata; Hidetaka Eguchi; Junichi Tamaru; Takeo Iwama
Journal:  Surg Today       Date:  2015-08-07       Impact factor: 2.549

2.  Rhabdoid colorectal carcinomas: reports of two cases.

Authors:  Sang Hwa Lee; Hyesil Seol; Wook Youn Kim; So Dug Lim; Wan Seop Kim; Tae Sook Hwang; Hye Seung Han
Journal:  Korean J Pathol       Date:  2013-08-26

Review 3.  Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer.

Authors:  Jung Ho Kim; Gyeong Hoon Kang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

4.  Association between mismatch repair gene and irinotecan-based chemotherapy in metastatic colon cancer.

Authors:  Junli Ma; Yan Zhang; Hong Shen; Linda Kapesa; Wenqiang Liu; Mengsi Zeng; Shan Zeng
Journal:  Tumour Biol       Date:  2015-07-05

5.  DBC1 is over-expressed and associated with poor prognosis in colorectal cancer.

Authors:  Yongguo Zhang; Yong Gu; Sumei Sha; Xiangyun Kong; Hongwu Zhu; Bin Xu; Yijun Li; Kaichun Wu
Journal:  Int J Clin Oncol       Date:  2013-01-09       Impact factor: 3.402

6.  Organ Specific Tumor Markers: What's New?

Authors:  Kannan Vaidyanathan; D M Vasudevan
Journal:  Indian J Clin Biochem       Date:  2011-11-08

Review 7.  Integrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer.

Authors:  Lorenzo F Sempere
Journal:  Expert Rev Mol Diagn       Date:  2011-11       Impact factor: 5.225

8.  Predictive markers for the response to 5-fluorouracil therapy in cancer cells: Constant-field gel electrophoresis as a tool for prediction of response to 5-fluorouracil-based chemotherapy.

Authors:  E M Saleh; R A El-Awady; N Anis
Journal:  Oncol Lett       Date:  2012-10-11       Impact factor: 2.967

9.  Loss of the proteins Bak and Bax prevents apoptosis mediated by histone deacetylase inhibitors.

Authors:  Caterina Ierano; Arup R Chakraborty; Alina Nicolae; Julian C Bahr; Zhirong Zhan; Stefania Pittaluga; Susan E Bates; Robert W Robey
Journal:  Cell Cycle       Date:  2013-08-07       Impact factor: 4.534

10.  Era of universal testing of microsatellite instability in colorectal cancer.

Authors:  Xuchen Zhang; Jia Li
Journal:  World J Gastrointest Oncol       Date:  2013-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.